この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2018/4/91 分で読めます
Pregnant Women: Scientific and Ethical Considerations for Inclusion in Clinical Trials; Draft Guidance; Availability
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Pregnant Women: Scientific and Ethical Considerations for Inclusion in Clinical Trials." This draft guidance discusses the ethical and scientific issues when considering the inclusion of pregnant women in clinical trials of drugs and biological products. This draft guidance is intended to advance scientific research in pregnant women, and discusses issues that should be considered within the framework of human subject protection regulations.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →